Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia

11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia

US Patent 7329683 · Granted Feb 12, 2008

Estimated economic value: $61,671,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EP2 antagonist compounds2025
Compositions and methods for the treatment of viral infections2023
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of can2022
Heteroaryl-substituted triazoles as APJ receptor agonists2021
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2021
Substituted quinolizine derivatives useful as HIV integrase inhibitors2020
Compounds that are ERK inhibitors2020
Piperidine or piperazine linked imidazole and triazole derivatives and methods o2020
Triazole furan compounds as agonists of the APJ receptor2020
Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors2020
Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors2020
Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors2020